Viewing Study NCT06807593


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2025-12-31 @ 1:38 PM
Study NCT ID: NCT06807593
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-07
First Post: 2025-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module